Press releaseBusiness Wire
VanEck Long/Flat Trend ETF
LFEQ · ETF
$60.53−$0.2969 (−0.49%)TodayMarket closed ·
Prev close $60.83
About LFEQ
- Issuer
- VanEck
- Tracks
- Ned Davis Research CMG US Large Cap Long/Flat Index
- Expense ratio
- 0.58%
- Assets under management
- $27.72M
- Inception
- Oct 4, 2017
- Asset class
- Equity
- Website
- vaneck.com
LFEQ key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 719
- Volume
- 151
- Open price
- $60.53
- High today
- $60.53
- Low today
- $60.53
- 52 Week high
- $62.16
- 52 Week low
- $50.27
VanEck Long/Flat Trend ETF (LFEQ) at a glance
As of Oct 23, 2026, VanEck Long/Flat Trend ETF (LFEQ) shares are priced at $60.53, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.
Volume so far is 151 shares, below the average of 719 shares a day.
Over the past year VanEck Long/Flat Trend ETF has ranged from $50.27 to $62.16, and now sits 86% of the way up that range.
LFEQ news
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.